Zdeněk Kořı́stek

University of Ostrava — Czech Republic

Medicine · Health Sciences

18h-index1.3kcitations220works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(45), Acute Myeloid Leukemia Research(33), Multiple Myeloma Research and Treatments(30), Chronic Lymphocytic Leukemia Research(29), Chronic Myeloid Leukemia Treatments(27)

Publications220 total

Clinical value of advanced genomic testing in adult Philadelphia-negative B-ALL: Results from the CZ national leukemia study group (CELL)
Blood·2025Open Access
Subgroup analyses from the randomized, Phase 3 VERONA study of venetoclax with azacitidine (Ven+Aza) versus placebo with azacitidine (Pbo+Aza) in patients with treatment-naïve, intermediate and higher-risk Myelodysplastic Syndromes (HR MDS)
Blood·2025· 1 cited
ORAL ABSTRACT: MDS-1497 Primary Analysis of the Randomized, Phase 3 VERONA Study of Venetoclax With Azacitidine Versus Placebo With Azacitidine in Patients With Treatment-Naïve, Intermediate and Higher-Risk Myelodysplastic Syndromes
Clinical Lymphoma Myeloma & Leukemia·2025
MDS-1497: Primary Analysis of the Randomized, Phase 3 VERONA Study of Venetoclax With Azacitidine Versus Placebo With Azacitidine in Patients With Treatment-Naïve, Intermediate and Higher-Risk Myelodysplastic Syndromes
Clinical Lymphoma Myeloma & Leukemia·2025· 3 cited
POSTER: MDS-1497 Primary Analysis of the Randomized, Phase 3 VERONA Study of Venetoclax With Azacitidine Versus Placebo With Azacitidine in Patients With Treatment-Naïve, Intermediate and Higher-Risk Myelodysplastic Syndromes
Clinical Lymphoma Myeloma & Leukemia·2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis
Leukemia·2025· 3 citedOpen Access
A peripherally inserted central catheter offers a secure and reliable method of venous access for patients newly diagnosed with acute promyelocytic leukaemia
The Journal of Vascular Access·2025
Real-World Experience With Venetoclax-Based Therapy in Acute Myeloid Leukemia: Insights From the Czech Republic
Clinical Lymphoma Myeloma & Leukemia·2025
Blinatumomab in induction therapy improves molecular response in untreated adults with Ph- B-cell precursor acute lymphoblastic leukemia
Haematologica·2025Open Access
Level of Clonal Plasma Cells in Hematopoietic Cell Autografts Reflects the Pre‐Transplant Bone Marrow Minimal Residual Disease in Multiple Myeloma Patients
American Journal of Hematology·2025· 2 citedOpen Access
One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID‐19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic
Cancer Medicine·2024Open Access
Predictive Value of Clonal Plasma Cells in Autografts Assessed By Next Generation Flow Cytometry on Pre-Transplant Bone Marrow MRD in Multiple Myeloma Patients
Blood·2024· 1 citedOpen Access
Central Nervous System Involvement Does Not Worsen Survival in Hematologic or Molecular Relapse of Adult Acute Lymphoblastic Leukemia Patients - Retrospective Analysis By the Czech Leukemia Study Group for Life (CELL)
Blood·2024Open Access
Real World Experience with Venetoclax-Based Therapy in Acute Myeloid Leukemia in the Czech Republic
Blood·2024
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study
British Journal of Haematology·2024· 15 citedOpen Access
Therapeutic plasma exchange in the treatment of thrombotic microangiopathies
Transfuze a hematologie dnes·2024
Oral Decitabine/Cedazuridine Vs Intravenous Decitabine for Acute Myeloid Leukemia: Final Results of a Randomized, Crossover, Registration-Enabling, Pharmacokinetics Study
Blood·2023· 4 cited
Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007–2020
Klinicka onkologie·2023Open Access
Insight into the mechanism of <scp>CD34</scp><sup>+</sup> cell mobilisation impairment in multiple myeloma patients treated with <scp>anti‐CD38</scp> therapy
British Journal of Haematology·2023· 15 citedOpen Access
P388: THERAPY OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON PEDIATRIC-INSPIRED PROTOCOLS IN THE CZECH REPUBLIC IN 2007–2020
HemaSphere·2023Open Access
page 1 of 11Next →

Frequent Co-authors

Jiřı́ Mayer(22), Roman Hájek(11), Milan Navrátil(9), Tomáš Jelı́nek(9), Grzegorz Basak(8), Ozren Jakšić(8), Gábor Mikala(8), Martin Klabusay(7), Michael Doubek(7), Kai Hübel(6), Michal Šimíček(6), Mohamad Mohty(5), Jane F. Apperley(5), Catarina Geraldes(5), Francesco Lanza(5), Roberto M. Lemoli(5), Dominik Selleslag(5), Nina Worel(5), Rafael F. Duarte(5), Jaroslav Meluzı́n(5)